Environmental control of invasiveness and metastatic dissemination of tumor cells: The role of tumor cell-host cell interactions

Cell Communication and Signaling

Volumn 8, Issue , 2010, Pages

  Calorini, Lido ^a   Bianchini, Francesca ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77956460390     PISSN: None     EISSN: 1478811X     Source Type: Journal    
DOI: 10.1186/1478-811X-8-24     Document Type: Review

References (97)

1. Cancer metastasis: building a framework. GP Gupta, J Massague, Cell 2006 127 679 695 10.1016/j.cell.2006.11.001 17110329
2. Illuminating the metastatic process. E Sahai, Nat Rev Cancer 2007 7 737 749 10.1038/nrc2229 17891189
3. Metastasis: from dissemination to organ-specific colonization. DX Nguyen, PD Bos, J Massagué Nat Rev Cancer 2009 9 274 284 10.1038/nrc2622 19308067
4. The cellular basis of tumor progression. GH Heppner, FR Miller, Int Rev Cytol 1998 177 1 56 10.1016/S0074-7696(08)62230-5 9378615
5. Tumor heterogeneity and the biology of cancer invasion and metastasis. IJ Fidler, Cancer Res 1978 38 2651 2660 354778
6. The experimental study of tumor progression: a review. L Foulds, Cancer Res 1954 14 327 339 13160960
7. Tumor progression, oncogenes and the evolution of metastatic phenotypic diversity. GL Nicolson, Clin Exp Metastasis 1984 2 85 105 10.1007/BF00052411 6543697
8. Cellular interactions in metastasis. FR Miller, GH Heppner, Cancer Metastasis Rev 1990 9 21 34 10.1007/BF00047586 2208566
9. Tumor-microenvironment interactions: dangerous liaisons. IP Witz, Adv Cancer Res 2008 100 203 29 full-text 18620097
10. Effect of dietary fat on human breast cancer growth and lung metastasis in nude mice. DP Rose, JM Connolly, CL Meschter, J Natl Cancer Inst 1991 83 1491 1495 10.1093/jnci/83.20.1491 1920496
11. Effects of linoleic acid on the growth and metastasis of two human breast cancer cell lines in nude mice and the invasive capacity of these cell lines in vitro. DP Rose, JM Connolly, XH Liu, Cancer Res 1994 54 6557 6562 7987856
12. The inhibition of lung colonization of B16-F10 melanoma cells in EFA-deficient animals is related to enhanced apoptosis and reduced angiogenesis. A Mannini, A Calzolari, L Calorini, G Mugnai, S Ruggieri, Clin Exp Metastasis 2006 23 1591 65 10.1007/s10585-006-9022-1
13. Diet and cancer-the European Prospective Investigation into Cancer and Nutrition. S Bingham, E Riboli, Nat Rev Cancer 2004 4 3:206 215 10.1038/nrc1298
14. Metastasis and neuroendocrine system in stressed mice. T Giraldi, L Perissin, S Zorzet, V Rapozzi, Ann N Y Acad Sc 1992 650 297 301 10.1111/j.1749-6632.1992.tb49140.x
15. Inflammation and cancer. LM Coussens, Z Werb, Nature 2002 420 860 867 10.1038/nature01322 12490959
16. Soluble mediators of inflammation during tumor development. SC Robinson, LM Coussens, Adv Cancer Res 2005 93 159 187 10.1016/S0065-230X(05)93005-4 15797447
17. Cancer-related inflammation. A Mantovani, P Allavena, A Sica, F Balkwill, Nature 2008 454 436 44 10.1038/nature07205 18650914
18. Role of plasma, platelets and endothelial cells in tumor metastasis. GJ Gasic, Cancer Metastasis Rev 1986 3 99 116
19. De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent. KE de Visser, LV Korets, LM Coussens, Cancer Cell 2005 7 411 423 10.1016/j.ccr.2005.04.014 15894262
20. The intriguing role of polymorphonuclear neutrophils in antitumor reactions. E Di Carlo, G Forni, P Lollini, MP Colombo, A Modesti, P Musiani, Blood 2001 97 339 345 10.1182/blood.V97.2.339 11154206
21. The potential role of neutrophils in promoting the metastatic phenotype of tumors releasing interleukin-8. JE De Larco, BR Wuertz, LT Furcht, Clin Cancer Res 2004 10 4895 4900 10.1158/1078-0432.CCR-03-0760 15297389
22. The fibroblast: sentinel cell and local immune modulator in tumor tissue. T Silzle, GJ Randolph, M Kreutz, LA Kunz-Schughart, Int J Cancer 2004 108 173 180 10.1002/ijc.11542 14639599
23. Fibroblasts in cancer. R Kalluri, M Zeisberg, Nat Rev Cancer 2006 6 392 401 10.1038/nrc1877 16572188
24. Carcinoma-associated fibroblasts are a rate-limiting determinant for tumour progression. Masayuki Shimoda, Kieran T Mellodyb, Akira Orimo, Semin Cell Dev Biol 2010 21 19 25 10.1016/j.semcdb.2009.10.002 19857592
25. The role of fibroblasts in tumor behaviour. M Grégoire, B Lieubeau, Cancer Metastasis Rev 1995 14 339 350 10.1007/BF00690602 8821094
26. Macrophage diversity enhances tumor progression and metastasis. BZ Qian, JW Pollard, Cell 2010 141 39 51 10.1016/j.cell.2010.03.014 20371344
27. La mala educación of tumor-associated macrophages: Diverse pathways and new players. A Mantovani, Cancer Cell 2010 17 111 112 10.1016/j.ccr.2010.01.019 20159603
28. Contact interactions between cells that suppress neoplastic development: can they also explain metastatic dormancy? H Rubin, Adv Cancer Res 2008 100 159 202 full-text 18620096
29. Models, mechanisms and clinical evidence for cancer dormancy. JA Aguirre-Ghiso, Nat Rev Cancer 2007 7 834 846 10.1038/nrc2256 17957189
30. Cancer progression and growth: relationship of paracrine and autocrine growth mechanisms to organ preference of metastasis. GL Nicolson, Exp Cell Res 1993 204 171 80 10.1006/excr.1993.1022 8382620
31. Macrophage infiltration and tumor progression. SJ Normann, Cancer Metastasis Rev 1985 4 277 291 10.1007/BF00048093 3907821
32. Macrophage content of spontaneous metastases at different stages of growth. PJ Bugelski, SP Corwin, SM North, RL Kirsh, GL Nicolson, G Poste, Cancer Res 1987 47 4141 4145 3300960
33. Impaired tumor growth in colony-stimulating factor 1 (CSF-1)-deficient, macrophage-deficient op/op mouse: evidence for a role of CSF-1-dependent macrophages in formation of tumor stroma. A Nowicki, J Szenajch, G Ostrowska, A Wojtowicz, K Wojtowicz, AA Kruszewski, M Maruszynski, SL Aukerman, W Wiktor-Jedrzejczak, Int J Cancer 1996 65 112 119 10.1002/(SICI)1097- 0215(19960103)65:1<112::AID-IJC19>3.0.CO;2-I 8543387
34. Colony-stimulating factor promotes progression of mammary tumors to malignancy. EY Lin, AV Nguyen, RG Russel, JW Pollard, J Exp Med 2001 193 727 740 10.1084/jem.193.6.727 11257139
35. Chemokines in the recruitment and shaping of the leukocyte infiltrate of tumors. A Mantovani, P Allavena, S Sozzani, A Vecchi, M Locati, A Sica, Semin Cancer Biol 2004 14 155 160 10.1016/j.semcancer.2003.10.001 15246050
36. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. B Barleon, S Sozzani, D Zhou, HA Weich, A Mantovani, D Marmé Blood 1996 87 3336 3343 8605350
37. The macrophage growth factor CSF-1 in mammary gland development and tumor progression. EY Lin, V Gouon-Evans, AV Nguyen, JW Pollard, J Mammary Gland Biol Neoplasia 2002 7 147 162 10.1023/A:1020399802795 12465600
38. Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. C Murdoch, A Giannoudis, CE Lewis, Blood 2004 104 2224 2234 10.1182/blood-2004-03-1109 15231578
39. Hypoxia, gene expression, and metastasis. DA Chan, AJ Giaccia, Cancer Metastasis Rev 2007 26 333 339 10.1007/s10555-007-9063-1 17458506
40. Hypoxia-inducible factors, stem cells, and cancer. B Keith, MC Simon, Cell 2007 129 465 472 10.1016/j.cell.2007.04.019 17482542
41. Recognition and destruction of neoplastic cells by activated macrophages: discrimination of altered self. IJ Fidler, AJ Schroit, Biochim Biophys Acta 1998 948 151 73
42. Monocyte and macrophage heterogeneity. S Gordon, PR Taylor, Nat Rev Immunol 2005 5 953 964 10.1038/nri1733 16322748
43. Macrophage polarization:tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. A Mantovani, S Sozzani, M Locati, P Allavena, A Sica, Trends Immunol 2002 23 549 555 10.1016/S1471-4906(02)02302-5 12401408
44. The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance. P Allavena, A Sica, C Garlanda, A Mantovani, Immunol Rev 2008 222 155 161 10.1111/j.1600-065X.2008.00607.x 18364000
45. A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3/STAT1 activation). SK Biswas, L Gangi, S Paul, T Schioppa, A Saccani, M Sironi, B Bottazzi, A Doni, B Vincenzo, F Pasqualini, L Vago, M Nebuloni, A Mantovani, A Sica, Blood 2006 107 2112 2122 10.1182/blood-2005-01-0428 16269622
46. Altered macrophage differentiation and immune dysfunction in tumor development. A Sica, V Bronte, J Clin Invest 2007 117 1155 1166 10.1172/JCI31422 17476345
47. Ornithine decarboxylase activity is critical for cell transformation. M Auvinen, A Paasinen, LC Andersson, E Holtta, Nature 1992 360 355 358 10.1038/360355a0 1280331
48. Macrophage arginine metabolism and the inhibition or stimulation of cancer. CD Mills, J Shearer, R Evans, MD Caldwell, J Immunol 1992 149 2709 2714 1401910
49. Macrophage arginase promotes tumor cell growth and suppresses nitric oxide-mediated tumor cytotoxicity. CI Chang, JC Liao, L Kuo, Cancer Res 2001 61 1100 1106 11221839
50. Role of nitric oxide in angiogenesis and microcirculation in tumors. D Fukumura, RK Jain, Cancer Metastasis Rev 1998 17 77 89 10.1023/A:1005908805527 9544424
51. Macrophages regulate the angiogenic switch in a mouse model of breast cancer. EY Lin, JF Li, L Gnatovskiy, Y Deng, L Zhu, DA Grzesik, H Qian, XN Xue, JW Pollard, Cancer Res 2006 66 11238 11246 10.1158/0008-5472.CAN-06-1278 17114237
52. Tumor-associated macrophages press the angiogenic switch in breast cancer. EY Lin, JW Pollard, Cancer Res 2007 67 5064 6 10.1158/0008-5472.CAN-07- 0912 17545580
53. Cytokine networks in solid human tumors: regulation of angiogenesis. RD Leek, AL Harris, CE Lewis, J Leukoc Biol 1994 56 423 35 7523556
54. Macrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma: possible involvement of TNFalpha and IL-1alpha. H Torisu, M Ono, H Kiryu, M Furue, Y Ohmoto, J Nakayama, Y Nishioka, S Sone, M Kuwano, Int J Cancer 2000 85 182 8 10629075
55. Angiogenin expression in human colorectal cancer: the role of focal macrophage infiltration. T Etoh, K Shibuta, GF Barnard, S Kitano, M Mori, Clin Cancer Re 2000 6 3545 51
56. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. G Bergers, R Brekken, G McMahon, TH Vu, T Itoh, K Tamaki, K Tanzawa, P Thorpe, S Itohara, Z Werb, D Hanahan, Nat Cell Biol 2000 2 737 44 10.1038/35036374 11025665
57. Tumor angiogenesis and progression are enhanced by Sema4 D produced by tumor-associated macrophages. JR Sierra, S Corso, L Caione, V Cepero, P Conrotto, A Cignetti, W Piacibello, A Kumanogoh, H Kikutani, PM Comoglio, L Tamagnone, S Giordano, J Exp Med 2008 205 1673 1685 10.1084/jem.20072602 18559453
58. Angiogenesis in cancer and other diseases. P Carmeliet, RK Jain, Nature 2000 407 249 257 10.1038/35025220 11001068
59. Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors. JB Wyckoff, Y Wang, EY Lin, JF Li, S Goswami, ER Stanley, JE Segall, JW Pollard, J Condeelis, Cancer Res 2007 67 2649 2656 10.1158/0008-5472.CAN-06-1823 17363585
60. Gene expression analysis of macrophages that facilitate tumor invasion supports a role for Wnt-signaling in mediating their activity in primary mammary tumors. LS Ojalvo, CA Whittaker, JS Condeelis, JW Pollard, J Immunol 2010 184 702 712 10.4049/jimmunol.0902360 20018620
61. Tumour-educated macrophages promote tumour progression and metastasis. JW Pollard, Nat Rev Cancer 2004 4 71 78 10.1038/nrc1256 14708027
62. Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop. S Goswami, E Sahai, JB Wyckoff, M Cammer, D Cox, FJ Pixley, ER Stanley, JE Segall, JS Condeelis, Cancer Res 2005 65 5278 5283 10.1158/0008-5472.CAN-04-1853 15958574
63. Arginine metabolism in tumor-associated macrophages in cutaneous malignant melanoma: evidence from human and experimental tumors. D Massi, C Marconi, A Franchi, F Bianchini, M Paglierani, S Ketabchi, C Miracco, M Santucci, L Calorini, Hum Pathol 2007 38 1516 1525 10.1016/j.humpath.2007.02.018 17640716
64. Expression of cyclo-oxygenase-2 in macrophages associated with cutaneous melanoma at different stages of progression. F Bianchini, D Massi, C Marconi, A Franchi, G Baroni, M Santucci, A Mannini, G Mugnai, L Calorini, Prostaglandins Other Lipid Mediat 2007 83 320 328 10.1016/j.prostaglandins.2007.03.003 17499752
65. Cytokine-dependent invasiveness in B16 murine melanoma cells: role of uPA system and MMP-9. F Bianchini, S D'Alessio, G Fibbi, M Del Rosso, L Calorini, Oncol Rep 2006 15 709 714 16465434
66. New functions for the matrix metalloproteinases in cancer progression. M Egeblad, Z Werb, Nat Rev Cancer 2002 2 161 174 10.1038/nrc745 11990853
67. MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. S Hiratsuka, K Nakamura, S Iwai, M Murakami, T Itoh, H Kijima, JM Shipley, RM Senior, M Shibuya, Cancer Cell 2002 2 289 300 10.1016/S1535-6108(02)00153-8 12398893
68. Multiple pathways of cell invasion are regulated by multiple families of serine proteases. M Del Rosso, G Fibbi, M Pucci, S D'Alessio, A Del Rosso, L Magnelli, V Chiarugi, Clin Exp Metastasis 2002 19 193 207 10.1023/A: 1015531321445 12067200
69. The urokinase plasminogen activator system in cancer: recent advances and implication for prognosis and therapy. N Sidenius, F Blasi, Cancer Metastasis Rev 2003 22 205 222 10.1023/A:1023099415940 12784997
70. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. EY Lin, AV Nguyen, RG Russell, JW Pollard, J Exp Med 2001 193 727 740 10.1084/jem.193.6.727 11257139
71. Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases. EY Lin, JG Jones, P Li, L Zhu, KD Whitney, WJ Muller, JW Pollard, Am J Pathol 2003 163 2113 2126 14578209
72. Enhancement of lung-colonizing potential of murine tumor cell lines co-cultivated with activated macrophages. O Cecconi, L Calorini, A Mannini, G Mugnai, S Ruggieri, Clin Exp Metastasis 1997 15 94 101 10.1023/A:1018440508189 9062385
73. Biological properties associated with the enhanced lung-colonizing potential in a B16 murine melanoma line grown in a medium conditioned by syngeneic Corynebacterium parvum-elicited macrophages. L Calorini, A Mannini, F Bianchini, G Mugnai, M Balzi, A Becciolini, S Ruggieri, Clin Exp Metastasis 1999 17 889 895 10.1023/A:1006783431599 11089888
74. IFN gamma and TNF alpha account for a pro-clonogenic activity secreted by activated murine peritoneal macrophages. L Calorini, F Bianchini, A Mannini, G Mugnai, M Balzi, A Becciolini, S Ruggieri, Clin Exp Metastasis 2002 19 259 264 10.1023/A:1015583322354 12067206
75. A distinct macrophage population mediates metastatic breast cancer cell extravasation, establishment and growth. B Qian, Y Deng, JH Im, RJ Muschel, Y Zou, J Li, RA Lang, JW Pollard, PLoS One 2009 4 6562 10.1371/journal.pone. 0006562 19668347
76. Tumour-stroma interaction: cancer-associated fibroblasts as novel targets in anti-cancer therapy? P Micke, A Ostman, Lung Cancer 2004 45 Suppl 2 163 75 10.1016/j.lungcan.2004.07.977 15552797
77. Fibroblasts in cancer. R Kalluri, M Zeisberg, Nat Rev Cancer 2006 6 392 401 10.1038/nrc1877 16572188
78. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. HF Dvorak, N Engl J Med 1986 315 1650 1659 10.1056/NEJM198612253152606 3537791
79. Transplantation of colon carcinoma into granulation tissue induces an invasive morphotype. KP Dingemans, IM Zeeman-Boeschoten, RF Keep, PK Das, Int J Cancer 1993 54 1010 1016 10.1002/ijc.2910540625 8335394
80. The myofibroblast: one function, multiple origins. B Hinz, SH Phan, VJ Thannickal, A Galli, ML Bochaton-Piallat, G Gabbiani, Am J Pathol 2007 170 1807 1816 10.2353/ajpath.2007.070112 17525249
81. Carcinoma-associated fibroblasts are a rate-limiting determinant for tumour progression. M Shimoda, KT Mellody, A Orimo, Semin Cell Dev Biol 2010 21 19 25 10.1016/j.semcdb.2009.10.002 19857592
82. Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells. A Lochter, S Galosy, J Muschler, N Freedman, Z Werb, MJ Bissell, J Cell Biol 1997 139 1861 1872 10.1083/jcb.139.7.1861 9412478
83. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. K Polyak, RA Weinberg, Nat Rev Cancer 2009 9 265 273 10.1038/nrc2620 19262571
84. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. A Orimo, PB Gupta, DC Sgroi, F Arenzana-Seisdedos, T Delaunay, R Naeem, VJ Carey, AL Richardson, RA Weinberg, Cell 2005 121 335 348 10.1016/j.cell.2005.02.034 15882617
85. Combined total genome loss of heterozygosity scan of breast cancer stroma and epithelium reveals multiplicity of stromal targets. K Fukino, L Shen, S Matsumoto, CD Morrison, GL Mutter, C Eng, Cancer Res 2004 64 7231 7236 10.1158/0008-5472.CAN-04-2866 15492239
86. Fibroblasts isolated from common sites of breast cancer metastasis enhance cancer cell growth rates and invasiveness in an interleukin-6-dependent manner. AW Studebaker, G Storci, JL Werbeck, P Sansone, AK Sasser, S Tavolari, T Huang, MW Chan, FC Marini, TJ Rosol, M Bonafé BM Hall, Cancer Res 2008 68 9087 9095 10.1158/0008-5472.CAN-08-0400 18974155
87. Enhancement of tumor invasion depends on transdifferentiation of skin fibroblasts mediated by reactive oxygen species. B Cat, D Stuhlmann, H Steinbrenner, L Alili, O Holtkötter, H Sies, P Brenneisen, J Cell Sci 2006 119 2727 38 10.1242/jcs.03011 16757516
88. Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. A Krtolica, S Parrinello, S Lockett, PY Desprez, J Campisi, Proc Natl Acad Sci USA 2001 98 12072 12077 10.1073/pnas.211053698 11593017
89. Cancer-Associated Fibroblasts are activated in incipient neoplasia to orchestrate tumor-promoting inflammation in an NF-kappaB-dependent manner. N Erez, M Truitt, P Olson, D Hanahan, Cancer Cell 2010 17 135 47 10.1016/j.ccr.2009.12.041 20138012
90. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment. LW Chung, A Baseman, V Assikis, HE Zhau, J Urol 2005 173 10 20 10.1097/01.ju.0000141582.15218.10 15592017
91. Co-inoculation of tumorigenic rat prostate mesenchymal cells with non-tumorigenic epithelial cells results in the development of carcinosarcoma in syngeneic and athymic animals. LW Chung, SM Chang, C Bell, HE Zhau, JY Ro, AC von Eschenbach, Int J Cancer 1989 43 1179 1187 10.1002/ijc.2910430636 2732007
92. Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling. JA Tuxhorn, GE Ayala, MJ Smith, VC Smith, TD Dang, DR Rowley, Clin Cancer Res 2002 8 2912 2923 12231536
93. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. AF Olumi, GD Grossfeld, SW Hayward, PR Carroll, TD Tlsty, GR Cunha, Cancer Res 1999 59 5002 5011 10519415
94. Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions. T Nakamura, K Matsumoto, A Kiritoshi, Y Tano, T Nakamura, Cancer Res 1997 57 3305 3313 9242465
95. Selective evolution of stromal mesenchyme with p53 loss in response to epithelial tumorigenesis. R Hill, Y Song, RD Cardiff, T Van Dyke, Cell 2005 123 1001 1011 10.1016/j.cell.2005.09.030 16360031
96. Heterogeneity of stromal fibroblasts in tumors. A Orimo, RA Weinberg, Cancer Biol Ther 2007 6 618 619 18027438
97. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. AE Karnoub, AB Dash, AP Vo, A Sullivan, MW Brooks, GW Bell, AL Richardson, K Polyak, R Tubo, RA Weinberg, Nature 2007 449 557 63 10.1038/nature06188 17914389